Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software

The global disruption caused by the 2020 coronavirus pandemic stressed the supply chain of many products, including pharmaceuticals. Multiple drug repurposing studies for COVID-19 are now underway. If a winning therapeutic emerges, it is unlikely that the existing inventory of the medicine, or even...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yingfu, Zhang, Zirong, Mahjour, Babak, Wang, Di, Zhang, Rui, Shim, Eunjae, McGrath, Andrew, Shen, Yuning, Brugger, Nadia, Turnbull, Rachel, Trice, Sarah, Jasty, Shashi, Cernak, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677791/
https://www.ncbi.nlm.nih.gov/pubmed/34916512
http://dx.doi.org/10.1038/s41467-021-27547-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677791/
https://www.ncbi.nlm.nih.gov/pubmed/34916512
http://dx.doi.org/10.1038/s41467-021-27547-3

Ejemplares similares